Global Medical REIT Inc. Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

During the year ended December 31, 2023, the following LTIP Units were issued by the Company:


		Number of
Date	Description	Units Issued	Vesting Dates

February 23, 2023	Final awards under the 2022 Annual Incentive Plan	68	50% on February 23, 2023; and
			50% on February 23, 2024

February 23, 2023	Time-based awards under the 2023 Long-Term Incentive Plan	165	100% on February 23, 2026

May 10, 2023	Annual awards to independent directors	45	100% on May 10, 2024

May 10, 2023	Discretionary awards	11	33.33% on May 10, 2024;
			33.33% on May 10, 2025; and
			33.33% on May 10, 2026


Vested units		2,270
Unvested units		486
LTIP Units outstanding as of December 31, 2023		2,756


2021 Long-Term Awards		67
2022 Long-Term Awards		96
2023 Annual Awards ⁽¹⁾		151
2023 Long-Term Awards ⁽²⁾		154
Total target performance awards as of December 31, 2023		468

(1)	Approved by the Board on May 10, 2023. The number of target LTIP Units was based on the average closing price of the Company’s common stock reported on the New York Stock Exchange (“NYSE”) over the 15 trading days preceding the award date.

(2)	Approved by the Board on February 23, 2023. The number of target LTIP Units was based on the fair value of the Long-Term Awards as determined by an independent valuation consultant.

Below are details regarding certain of the assumptions for the Long-Term Awards using Monte Carlo simulations: